Lisdexamfetamine, marketed as Vyvanse, is a prescription medication approved for attention deficit hyperactivity disorder in youngsters and grown-ups . In Canada, its distribution is managed by Health https://teva-lisdexamfetamine-on951724.review-blogger.com/64889418/vyvanse-in-canada-a-detailed-guide